Moving to the last two biological assays, AP-2α overexpression decreased the MMP-9 activity in G3, which is in line with colon cancer findings [69], and increased MMP-2 in G4, as observed by Kuckenberg et al. [70]. The gene discussed is MMP9; the disease is malignant colon neoplasm.